Monthly Archives: May 2018

Biothera Pharmaceuticals Appoints Andrew D.C. LaFrence Chief Financial Officer

EAGAN, MN — May 16, 2018 — Biothera Pharmaceuticals, Inc., announced the appointment of Andrew D.C. LaFrence, CPA as Senior Vice President and Chief Financial Officer, effective May 29.  Biothera Pharmaceuticals is a clinical stage immuno-oncology company developing a novel immunotherapy in combination with immune checkpoint inhibitors for multiple types of cancer. Mr. LaFrence has 34 years of accounting and finance experience, including executive management...

Read More